Published on August 21, 2013 at 8:09 AM
“One of our greatest health challenges is to develop highly-personalised interventions for teenagers and young adults with emerging mood disorders, like major depression or bipolar disorder,” he said.
“This new Australian centre combines our national expertise and links it with research innovation and training in key European and North American centres.
The centre will also set up a national databank recording illness outcomes of young people experiencing major mood disorders.
A research team led by Professor Ron Grunstein received funding for NeuroSleep: the Centre for Translational Sleep and Circadian Neurobiology Centre for Research Excellence
NeuroSleep will build on emerging collaborations between the Woolcock Institute, BMRI (both at The University of Sydney), Monash University Sleep Network and NeuRA (UNSW) to provide the clinical infrastructure and platforms to achieve aims which are beyond any single site.
Professor Grunstein said: “The key aim of NeuroSleep is to improve cognition, workplace safety, and health outcomes in patients with sleep problems such as shift workers, patients with sleep disorders, neurodegenerative and/or mental health problems.”
NeuroSleep will be a novel and distinct entity that will build on the success of the current Clinical CRE for Interdisciplinary Sleep Health (CIRUS), completing funding at the end of 2013.
Professor Grunstein said the NeuroSleep group would target three areas: the ageing populations; our 24/7 society and patient care.
“Our goal is to improve brain performance, workplace safety and health outcomes in patients with sleep and circadian dysfunction and in the general community.”